These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7026333

  • 1. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
    Luyckx AS, Mendoza E, Lefebvre PJ.
    Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D, Luyckx AS, Lefebvre PJ.
    J Endocrinol Invest; 1980 Oct; 3(1):19-23. PubMed ID: 6989887
    [Abstract] [Full Text] [Related]

  • 5. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M, Lehmann R, Maly FE, Schmid C, Spinas GA.
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [Abstract] [Full Text] [Related]

  • 6. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R, Verdonk C, Miles J, Service FJ, Gerich J.
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [Abstract] [Full Text] [Related]

  • 7. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP, Benson JW, Walter RM, Ensinck JW.
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T, Fukushima H, Uehara M, Wada S, Shirotani T, Kishikawa H, Ichinose K, Yamaguchi K, Shichiri M.
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [Abstract] [Full Text] [Related]

  • 10. Glucose regulation of glucagon secretion independent of B cell activity.
    Asplin C, Raghu P, Dornan T, Palmer JP.
    Metabolism; 1983 Mar; 32(3):292-5. PubMed ID: 6338350
    [Abstract] [Full Text] [Related]

  • 11. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC.
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [Abstract] [Full Text] [Related]

  • 12. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L, Holst JJ, Møller J, Orskov C, Møller N, Alberti KG, Schmitz O.
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [Abstract] [Full Text] [Related]

  • 13. How does glucose regulate the human pancreatic A cell in vivo?
    Asplin CM, Hollander PM, Palmer JP.
    Diabetologia; 1984 Mar; 26(3):203-7. PubMed ID: 6370770
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C, Faber OK, Drejer J, Binder C.
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
    Uitbeijerse BS, Nijhoff MF, de Koning EJP.
    Am J Physiol Endocrinol Metab; 2024 May 01; 326(5):E673-E680. PubMed ID: 38446636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.